Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C.

Reau, Nancy

Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C. [electronic resource] - The American journal of gastroenterology Mar 2011 - 452-8 p. digital

Publication Type: Journal Article

1572-0241

10.1038/ajg.2010.424 doi


Adult
Antiviral Agents--therapeutic use
Drug Carriers
Drug Therapy, Combination
Female
Follow-Up Studies
Genotype
Hepacivirus--drug effects
Hepatitis C--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--administration & dosage
Logistic Models
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Polyethylene Glycols--administration & dosage
Polymerase Chain Reaction
RNA, Viral--isolation & purification
Recombinant Proteins
Retrospective Studies
Ribavirin--therapeutic use
Treatment Failure
Treatment Outcome
Viral Load--drug effects